Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4012984011 | Symmetrical drug-related intertriginous and flexural exanthema | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4012985012 | Symmetrical drug-related intertriginous and flexural exanthema (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 414519015 | Baboon syndrome | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Pathological process (attribute) | Non-immunoglobulin E-mediated allergic contact hypersensitivity process | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | inflammation d'un organe corporel spécifique | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | Inflammatory morphology (morphologic abnormality) | false | Inferred relationship | Some | 3 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Pathological process (attribute) | Non-immunoglobulin E-mediated allergic contact hypersensitivity process | false | Inferred relationship | Some | 3 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | interprète (attribut) | prurit | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | dermatite de contact | true | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Pathological process (attribute) | Contact hypersensitivity process | true | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | Inflammatory morphology (morphologic abnormality) | true | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | Drug-induced dermatosis (disorder) | true | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | intertrigo (trouble) | true | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | affection inflammatoire d'une extrémité | true | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | localisation d'une constatation (attribut) | Gluteal sulcus structure | true | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Causative agent | Friction | true | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | Inflammatory morphology (morphologic abnormality) | true | Inferred relationship | Some | 2 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Pathological process (attribute) | Contact hypersensitivity process | true | Inferred relationship | Some | 2 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Causative agent | Drug or medicament (substance) | true | Inferred relationship | Some | 2 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | Disorder of lower extremity (disorder) | true | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | Disorder of abdominopelvic segment of trunk | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | Disorder of pelvic region of trunk (disorder) | true | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est défini par la manifestation de (attribut) | Immune system finding | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Due to | Allergic reaction (disorder) | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Causative agent | substance | false | Inferred relationship | Some | 2 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Due to | réaction d'hypersensibilité immunitaire | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Due to | Contact hypersensitivity reaction (disorder) | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | Chemical-induced dermatological disorder | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Due to | réaction d'hypersensibilité immunitaire | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | localisation d'une constatation (attribut) | structure de la peau | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | inflammation | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Pathological process (attribute) | Allergic process (qualifier value) | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | inflammation | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | localisation d'une constatation (attribut) | structure de la peau | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | inflammation | false | Inferred relationship | Some | 2 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | localisation d'une constatation (attribut) | structure de la peau | true | Inferred relationship | Some | 2 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Pathological process (attribute) | Hypersensitivity process (qualifier value) | false | Inferred relationship | Some | 2 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | Eruption | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Causative agent | Allergen | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Causative agent | Chemical categorized by structure (substance) | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | localisation d'une constatation (attribut) | structure du système immunitaire | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | morphologie associée (attribut) | Papulovesicular rash | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Causative agent | Drug | false | Inferred relationship | Some | ||
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | localisation d'une constatation (attribut) | structure de la peau | false | Inferred relationship | Some | 3 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Pathological process (attribute) | Allergic process (qualifier value) | false | Inferred relationship | Some | 1 | |
| Symmetrical drug-related intertriginous and flexural exanthema (disorder) | est un(e) (attribut) | Ingested allergen contact dermatitis | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| syndrome babouin d'origine médicamenteuse | est un(e) (attribut) | False | Symmetrical drug-related intertriginous and flexural exanthema (disorder) | Inferred relationship | Some |
Reference Sets
FHIR